Researchers eliminate leukemia in mice
Scientists have corrected a flaw in cancer cells that lets them evade the normal cell-death process, and as a result they eliminated leukemia cells from mice. With this achievement, the researchers confirm that a key anti-cell-death molecule called BCL-2 is required by many types of cancer cells to survive, and that silencing it with designer drugs may prove to be an effective new avenue for cancer therapy. Using drugs to manipulate apoptosis, or ”programmed cell death” in cancers ”is a new paradigm that hasn’t been well explored yet.”